Holen Sie sich die Stockscreener-App
26.18
0.04%
-0.045
Schlusskurs vom Vortag:
$26.13
Offen:
$26.46
24-Stunden-Volumen:
226.57K
Relative Volume:
0.12
Marktkapitalisierung:
$2.71B
Einnahmen:
$71.78M
Nettoeinkommen (Verlust:
$-295.28M
KGV:
-8.284
EPS:
-3.1597
Netto-Cashflow:
$-271.85M
1W Leistung:
+1.16%
1M Leistung:
+2.31%
6M Leistung:
+68.52%
1J Leistung:
+183.91%
1-Tages-Spanne:
$25.91
$26.70
1-Wochen-Bereich:
$24.95
$26.70
52-Wochen-Spanne:
$8.195
$28.23
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Firmenname
Nurix Therapeutics Inc
Sektor
Branche
Telefon
(415) 660-5320
Adresse
1600 SIERRA POINT PKWY, BRISBANE
Compare NRIX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
26.16 | 2.71B | 71.78M | -295.28M | -271.85M | -3.1597 |
VRTX
Vertex Pharmaceuticals Inc
|
522.23 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
800.17 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,000.06 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.54 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.27 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-24 | Fortgesetzt | Truist | Buy |
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-12-10 | Eingeleitet | BTIG Research | Buy |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | Jefferies | Buy |
| 2024-09-06 | Fortgesetzt | Robert W. Baird | Outperform |
| 2024-07-31 | Eingeleitet | Truist | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-09 | Eingeleitet | Barclays | Overweight |
| 2023-02-28 | Eingeleitet | Oppenheimer | Outperform |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-12-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-14 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-04-30 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2020-11-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum By Investing.com - Investing.com India
Nurix Therapeutics at Wells Fargo conference: pipeline, deal momentum - Investing.com
Legal & General Group Plc Buys Shares of 72,026 Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Stock Price Forecast. Should You Buy NRIX? - StockInvest.us
Wall Street Zen Downgrades Nurix Therapeutics (NASDAQ:NRIX) to Sell - MarketBeat
Bank of New York Mellon Corp Purchases New Shares in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares By Investing.com - Investing.com South Africa
Braidwell LP Cuts Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Nurix Therapeutics chief legal officer sells over $149k in shares - Investing.com
The Manufacturers Life Insurance Company Acquires New Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Man Group plc Makes New $2.08 Million Investment in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Alyeska Investment Group L.P. Takes $3.35 Million Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Behavioral Patterns of NRIX and Institutional Flows - Stock Traders Daily
Nurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 1,452 Shares of Stock - MarketBeat
Nurix Therapeutics to Participate in Upcoming September Investor Conferences - Yahoo Finance
Trails Edge Capital Partners LP Purchases New Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat
313,236 Shares in Nurix Therapeutics, Inc. $NRIX Acquired by ADAR1 Capital Management LLC - MarketBeat
58,898 Shares in Nurix Therapeutics, Inc. $NRIX Bought by Polymer Capital Management HK LTD - MarketBeat
Nurix Therapeutics: Roche Has Changed The Economics Of The Bull Case (NASDAQ:NRIX) - Seeking Alpha
Bank of America Corp DE Purchases 65,595 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Sahm
Edmond DE Rothschild Holding S.A. Invests $2.18 Million in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Deep Track Capital, LP Expands Nurix Therapeutics Inc (NRIX) Sta - GuruFocus
Nurix Therapeutics, Inc. (NRIX) Stock Price, News, Quote & History - Yahoo Finance
Top BridgeBio Oncology Therapeutics (BBOT) Competitors 2026 - MarketBeat
Press Release: Nurix Therapeutics Announces Appointment of Wes Burwell as Chief Human Resources Officer - Moomoo
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 12-Month HighShould You Buy? - MarketBeat
Nurix (NRIX) Results Review: The EPS Result Is Below Expectation for the Current Session; Post-Earnings: Shares Fall 0.88%EPS Growth Rate - Vinanet
Nurix Therapeutics (NRIX) Starts Phase 3 And Lands Sanofi Milestone, Is The Valuation About Right? - Sahm
Handelsbanken Fonder AB Buys 86,000 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics (NRIX) Is Up 6.0% After Milestone From Sanofi And Phase 3 Start With Roche - webull.com
Nurix Therapeutics stock hits 52-week high at $26.40 By Investing.com - Investing.com Nigeria
Nurix Therapeutics stock hits 52-week high at $26.40 - Investing.com
Sei Investments Co. Buys 46,132 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Understanding the Setup: (NRIX) and Scalable Risk - Stock Traders Daily
Nurix Therapeutics (NASDAQ:NRIX) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
NRIX Maintained by RBC Capital -- Price Target Raised to $36 - GuruFocus
Royal Bank Of Canada Boosts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $36.00 - MarketBeat
Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says - marketscreener.com
RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36 - Moomoo
RBC Adjusts PT on Nurix Therapeutics to $36 From $33, Maintains Outperform Speculative Risk Rating - marketscreener.com
Dimensional Fund Advisors LP Purchases 349,710 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Rating Increased to Hold at Wall Street Zen - MarketBeat
Nurix Therapeutics, Inc. (NRIX): A Biotech Stock with 32% Upside Potential and Strong Buy Ratings - DirectorsTalk Interviews
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 4,356 Shares of Stock - MarketBeat
Nurix Therapeutics stock hits 52-week high at $25.22 By Investing.com - Investing.com UK
Nurix Therapeutics (NRIX) Lands $10 Million Milestone As Phase 3 Trial Begins - Yahoo Finance
NRIX (NRIX) holder Hansen details option exercise and 10b5-1 stock sales - Stock Titan
Nurix Therapeutics stock hits 52-week high at $25.22 - Investing.com
Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nurix Therapeutics Inc-Aktie (NRIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ring Christine | Chief Legal Officer |
Sep 02 '26 |
Sale |
25.76 |
5,787 |
149,072 |
9,110 |
0.72%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):